SE402915B - PROCEDURE FOR THE PREPARATION OF IMIDAZO (5,1-F) TRIAZINONES WITH THERAPEUTIC EFFECT - Google Patents

PROCEDURE FOR THE PREPARATION OF IMIDAZO (5,1-F) TRIAZINONES WITH THERAPEUTIC EFFECT

Info

Publication number
SE402915B
SE402915B SE7214358A SE1435872A SE402915B SE 402915 B SE402915 B SE 402915B SE 7214358 A SE7214358 A SE 7214358A SE 1435872 A SE1435872 A SE 1435872A SE 402915 B SE402915 B SE 402915B
Authority
SE
Sweden
Prior art keywords
triazinones
imidazo
procedure
preparation
therapeutic effect
Prior art date
Application number
SE7214358A
Other languages
Swedish (sv)
Inventor
S C Garside
D Hartley
L H C Lunts
A W Oxford
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of SE402915B publication Critical patent/SE402915B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7214358A 1971-11-19 1972-11-06 PROCEDURE FOR THE PREPARATION OF IMIDAZO (5,1-F) TRIAZINONES WITH THERAPEUTIC EFFECT SE402915B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions

Publications (1)

Publication Number Publication Date
SE402915B true SE402915B (en) 1978-07-24

Family

ID=10468856

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7214358A SE402915B (en) 1971-11-19 1972-11-06 PROCEDURE FOR THE PREPARATION OF IMIDAZO (5,1-F) TRIAZINONES WITH THERAPEUTIC EFFECT

Country Status (18)

Country Link
US (1) US3840537A (en)
JP (1) JPS563873B2 (en)
AT (1) AT321923B (en)
AU (1) AU472127B2 (en)
BE (1) BE791025A (en)
CA (1) CA990292A (en)
CH (1) CH594671A5 (en)
DE (1) DE2255172A1 (en)
DK (1) DK138691B (en)
ES (1) ES408736A1 (en)
FR (1) FR2160407B1 (en)
GB (1) GB1400999A (en)
IE (1) IE37046B1 (en)
IL (1) IL40686A (en)
NL (1) NL7215646A (en)
PH (1) PH9669A (en)
SE (1) SE402915B (en)
ZA (1) ZA727532B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DE2314488C3 (en) * 1973-03-23 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 8- (2,6-Dichlorophenyl) -7- (4-chlorophenyl) -5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazine, process for its preparation and medicament containing it
DE2335193A1 (en) * 1973-07-11 1975-01-30 Hoechst Ag BIS-TRIAZINOBENZIMIDAZOLE AND THEIR PRODUCTION
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
US4107307A (en) * 1977-02-03 1978-08-15 American Cyanamid Company Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
USRE30511E (en) * 1977-02-03 1981-02-10 American Cyanamid Company Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
DK109578A (en) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd PROCEDURE FOR MAKING HETEROCYCLIC COMPOUNDS
US4107308A (en) * 1977-10-18 1978-08-15 American Cyanamid Company Imidazo[1,5-d]-as-triazines
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
HU187474B (en) * 1981-11-18 1986-01-28 Gyogyszerkutato Intezet,Hu Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives
US4395547A (en) * 1982-02-10 1983-07-26 American Cyanamid Co. Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
DE59803108D1 (en) * 1997-11-12 2002-03-21 Bayer Ag 2-PHENYL-SUBSTITUTED IMIDAZOTRIAZINONE AS PHOSPHODIESTERASE INHIBITORS
DE19827640A1 (en) * 1998-06-20 1999-12-23 Bayer Ag New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
EP1107747A4 (en) 1998-08-26 2003-04-23 Smithkline Beecham Corp Therapies for treating pulmonary diseases
PT1212089E (en) * 1999-08-21 2006-08-31 Altana Pharma Ag ROFLUMILAST AND SALMETEROL SYNERGY COMBINATION
BR0209541A (en) * 2001-05-09 2004-04-20 Bayer Healthcare Ag Use of 2-phenyl-substituted imidazotriazinones
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
GB0113344D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
DE10135815A1 (en) 2001-07-23 2003-02-06 Bayer Ag Use of imidazo-triazinone derivative phosphodiesterase 5 inhibitors e.g. for treatment of cardiac insufficiency, psoriasis, diabetes, cancer, glaucoma, bladder disease, Parkinson's disease or pain
DE10232113A1 (en) 2002-07-16 2004-01-29 Bayer Ag Medicinal products containing vardenafil hydrochloride trihydrate
US7462614B2 (en) * 2003-04-01 2008-12-09 Smithkline Beecham Corporation Imidazotriazine compounds
PT1740591E (en) 2004-04-02 2009-09-24 Osi Pharm Inc 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
DE102005001989A1 (en) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenous formulations of PDE inhibitors
DE102005009241A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with controlled bioavailability
DE102005009240A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with improved pharmacokinetic properties
KR20080056250A (en) * 2005-09-29 2008-06-20 바이엘 헬스케어 아게 Pde inhibitors and combinations thereof for the treatment of urological disorders
SI1951724T1 (en) 2005-11-17 2011-09-30 Osi Pharmaceuticals Llc FUSED BICYCLIC mTOR INHIBITORS
US20100184769A1 (en) * 2007-06-13 2010-07-22 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
JP2012524119A (en) 2009-04-20 2012-10-11 オーエスアイ・ファーマシューティカルズ，エルエルシー Preparation of C-pyrazine-methylamine
CN103374002B (en) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 Phosphodiesterase-5 inhibitor
JP2018508555A (en) * 2015-03-16 2018-03-29 大日本住友製薬株式会社 Bicyclic imidazolo derivatives
WO2017000276A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
WO2017204316A1 (en) * 2016-05-27 2017-11-30 塩野義製薬株式会社 5-oxo-1,2,4-triazine derivative, and pharmaceutical composition thereof

Also Published As

Publication number Publication date
FR2160407A1 (en) 1973-06-29
IL40686A (en) 1975-12-31
CA990292A (en) 1976-06-01
IE37046B1 (en) 1977-04-27
AT321923B (en) 1975-04-25
IE37046L (en) 1973-05-19
FR2160407B1 (en) 1975-10-17
JPS563873B2 (en) 1981-01-27
BE791025A (en) 1973-05-07
AU4819172A (en) 1974-05-16
GB1400999A (en) 1975-07-16
DK138691C (en) 1979-03-26
ES408736A1 (en) 1976-03-01
PH9669A (en) 1976-02-10
JPS4857993A (en) 1973-08-14
AU472127B2 (en) 1976-05-20
ZA727532B (en) 1973-07-25
DK138691B (en) 1978-10-16
CH594671A5 (en) 1978-01-13
IL40686A0 (en) 1972-12-29
NL7215646A (en) 1973-05-22
US3840537A (en) 1974-10-08
DE2255172A1 (en) 1973-05-24

Similar Documents

Publication Publication Date Title
SE402915B (en) PROCEDURE FOR THE PREPARATION OF IMIDAZO (5,1-F) TRIAZINONES WITH THERAPEUTIC EFFECT
SE405604B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF 1,2,4-TRIAZOLE-3-CARBOXAMIDE-1- (BETA-D-RIBOFURANOSYL)
SE384211B (en) PROCEDURE FOR THE PREPARATION OF 2-SUBSTITUTED-4-AMINO-6,7,8-TRIALCOXIKINAZOLINES
SE395890B (en) PROCEDURE FOR THE PREPARATION OF ANTHELMINTIC ACTIVITIES 2-CARBALCOXIAMINO-BENSIMIDAZOLE-5 (6) PHENYLETHERS
NO137012C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRAZOLO (1,5-A) PYRIMIDINES
SE405599B (en) PROCEDURE FOR THE PREPARATION OF PYRIDAZINONS WITH THERAPEUTIC EFFECT
FI54121C (en) PROCEDURE FOR THE FRAMSTATION OF THE BLODTRYCKSSAENKANDE IMIDAZO- (1,2-A) -IMIDAZOLER-PYRIMIDINER OCH DIAZEPINER OCH DERAS SYRAADDITIONSSALTER
SE396388B (en) ANALOGICAL PREPARATION FOR THE PREPARATION OF 2,3-DIHYDRO-OXO-IMIDAZO- / 1,2-A / PYRIMIDINES
SE395892B (en) PROCEDURE FOR THE PREPARATION OF PIPERIDYL-BENSIMIDAZOLINES WITH THERAPEUTIC EFFECT
SE398499B (en) PROCEDURE FOR THE PREPARATION OF 2,4,5,6-TETRAHYDROCYCLOPENTA / C / PURROL-4-CARBOXAMIDES AND -4-THIOCARBOXAMIDS WITH THERAPEUTIC EFFECT
SE386175B (en) PROCEDURE FOR THE PREPARATION OF 1,4-BIS-ACYLPIPERAZINES
SE380804B (en) ANOLOGY PROCEDURE FOR THE PREPARATION OF S-TRIAZOLO (1,5-A) (1,4)
SE7507887L (en) PROCEDURE FOR THE PREPARATION OF BENZOPYRANE COMPOUNDS WITH THERAPEUTIC EFFECT.
SE387936B (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED METHOXYAMINES
SE398122B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF PYRAZINO / 1,2-A / INDOL-2-CARBOXAMIDINES
SE390025B (en) PROCEDURE FOR THE PREPARATION OF 3 ALFA-HYDROXI-19-5 ALFA-PREGNAN-11,20-DION
SE409866B (en) PROCEDURE FOR THE PREPARATION OF ADENOSIN DERIVATIVES
SE380520B (en) PROCEDURE FOR THE PREPARATION OF 1-CINNAMYLIDENAMINO-3-BENZYLIDENAMINOGUANIDINE
SE393980B (en) PROCEDURE FOR THE PREPARATION OF 5- (OCH7-) BENZOYLINDOLIN-2-ONES WITH THERAPEUTIC EFFECT
SE395689B (en) PROCEDURE FOR THE PREPARATION OF CERTAIN STATED BENZALACETONAMIDINOHYDRAZONE DERIVATIVES
SE386897B (en) PROCEDURE FOR THE PREPARATION OF N-ACYL- (PIPERAZINOETHYL) -PYRAZOLES
SE394430B (en) PROCEDURE FOR THE PREPARATION OF INDOLYLALKYLAMAMES WITH THERAPEUTIC EFFECT
SE385897B (en) PROCEDURE FOR THE PREPARATION OF BENSODITIAN PYRONE DERIVATIVES WITH THERAPEUTIC EFFECT
SE400777B (en) PROCEDURE FOR THE PREPARATION OF 2,4-DIAMINO-5-BENZYLPYRIMIDINES WITH ANTIBACTERIAL EFFECT
FI56387B (en) FOERFARANDE FOER FRAMSTAELLNING AV ALKANSULFONSYRAESTRAR AV 1,3,2-OXAZAFOSFORINFOERENINGAR MED IMMUNITETSSAENKANDE VERKAN